{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:02:38Z","timestamp":1793656958978,"version":"4.5.1"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,1]]},"abstract":"Abstract<\/jats:title>\n \n Aims<\/jats:title>\n Renal failure due to intravascular haemolysis (IH) has been reported after pulsed field ablation (PFA) of atrial fibrillation (AF). However, IH incidence using the accepted laboratory criteria is unknown.<\/jats:p>\n <\/jats:sec>\n \n Methods and results<\/jats:title>\n In this prospective observational study (Sept 2024\u2013May 2025), consecutive patients undergoing PFA for AF with pentaspline (PS), circular array (CA), or lattice tip (LT) catheters were included. Pre- and post-procedural labs and haemolysis biomarkers were collected. Significant IH was defined as post-procedure free plasma haemoglobin &gt; 100\u2005mg\/dL per haematology criteria. Logistic regression (pooled and stratified) was used to identify IH predictors. Among 245 patients (66.9 \u00b1 10.6 years; 68.2% male; 48.2% persistent), PFA was performed using the LT (62), PS (108), or CA (75) catheters. There was a significant difference in the incidence of IH across technologies (37.0%, 26.1%, and 14.7% for PS, CA, and LT, P = 0.002). No demographic or clinical parameters were associated with higher IH risk, while the use of PS was the only independent predictor [odds ratio (OR) 3.42, P = 0.001] of IH. The number of PF lesions increased risk for IH only within the PS group (OR 1.03, P = 0.049). Routine post-ablation laboratories had poor sensitivity\/specificity to define severe IH.<\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n Although over 17% of the cohort met the haematologic definition for significant IH, the absence of clinically significant renal impairment suggests that this threshold may not accurately reflect clinically meaningful haemolysis following PFA. The absence of clinical predictors or laboratory surrogates suggests that the rare risk of renal injury must be balanced with the well-established benefits of PFA when lesions are delivered in moderation optimizing tissue contact.<\/jats:p>\n <\/jats:sec>","DOI":"10.1093\/europace\/euaf185","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T11:49:34Z","timestamp":1755690574000},"source":"Crossref","is-referenced-by-count":20,"title":["Incidence of laboratory-defined severe intravascular haemolysis across commercially available pulsed field ablation technologies for atrial fibrillation"],"prefix":"10.1093","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5641-3029","authenticated-orcid":false,"given":"Stavros E","family":"Mountantonakis","sequence":"first","affiliation":[{"name":"Center for Arrhythmias, Northwell Cardiovascular Institute , 2000 Marcus Ave, Suite 300, New Hyde Park, NY 11042-1069 , USA"},{"name":"Department of Electrophysiology, Lenox Hill Hospital, 100 East 77th Street, New York, NY 10075 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7567-6759","authenticated-orcid":false,"given":"Nicholas","family":"Beccarino","sequence":"additional","affiliation":[{"name":"Center for Arrhythmias, Northwell Cardiovascular Institute , 2000 Marcus Ave, Suite 300, New Hyde Park, NY 11042-1069 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0800-5730","authenticated-orcid":false,"given":"Humail","family":"Patel","sequence":"additional","affiliation":[{"name":"Center for Arrhythmias, Northwell Cardiovascular Institute , 2000 Marcus Ave, Suite 300, New Hyde Park, NY 11042-1069 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Castillo","sequence":"additional","affiliation":[{"name":"Center for Arrhythmias, Northwell Cardiovascular Institute , 2000 Marcus Ave, Suite 300, New Hyde Park, NY 11042-1069 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taha","family":"Siddiqui","sequence":"additional","affiliation":[{"name":"Center for Arrhythmias, Northwell Cardiovascular Institute , 2000 Marcus Ave, Suite 300, New Hyde Park, NY 11042-1069 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6546-7248","authenticated-orcid":false,"given":"Madhav","family":"Bhatt","sequence":"additional","affiliation":[{"name":"Center for Arrhythmias, Northwell Cardiovascular Institute , 2000 Marcus Ave, Suite 300, New Hyde Park, NY 11042-1069 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8026-1463","authenticated-orcid":false,"given":"Jonas","family":"Leavitt","sequence":"additional","affiliation":[{"name":"Center for Arrhythmias, Northwell Cardiovascular Institute , 2000 Marcus Ave, Suite 300, New Hyde Park, NY 11042-1069 , USA"},{"name":"Department of Electrophysiology, Lenox Hill Hospital, 100 East 77th Street, New York, NY 10075 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6616-8234","authenticated-orcid":false,"given":"Kristie M","family":"Coleman","sequence":"additional","affiliation":[{"name":"Center for Arrhythmias, Northwell Cardiovascular Institute , 2000 Marcus Ave, Suite 300, New Hyde Park, NY 11042-1069 , USA"},{"name":"Department of Electrophysiology, Lenox Hill Hospital, 100 East 77th Street, New York, NY 10075 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,8,22]]},"reference":[{"key":"2025092303562863700_euaf185-B1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcvm.2022.959186","article-title":"Initial experience with pulsed field ablation for atrial fibrillation","volume":"9","author":"Magni","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2025092303562863700_euaf185-B2","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ccep.2022.08.003","article-title":"Improvement in lesion formation with radiofrequency energy and utilization of alternate energy sources (cryoablation and pulsed field ablation) for ventricular arrhythmia ablation","volume":"14","author":"Nakagawa","year":"2022","journal-title":"Card Electrophysiol Clin"},{"key":"2025092303562863700_euaf185-B3","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1161\/CIRCEP.113.000768","article-title":"Complications of catheter ablation of atrial fibrillation: a systematic review","volume":"6","author":"Gupta","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025092303562863700_euaf185-B4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jacc.2019.04.021","article-title":"Pulsed field ablation for pulmonary vein isolation in atrial fibrillation","volume":"74","author":"Reddy","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2025092303562863700_euaf185-B5","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1161\/CIRCULATIONAHA.123.063988","article-title":"Pulsed field ablation for the treatment of atrial fibrillation: PULSED AF pivotal trial","volume":"147","author":"Verma","year":"2023","journal-title":"Circulation"},{"key":"2025092303562863700_euaf185-B6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/CIRCULATIONAHA.123.064959","article-title":"Safety and effectiveness of pulsed field ablation to treat atrial fibrillation: one-year outcomes from the MANIFEST-PF registry","volume":"148","author":"Turagam","year":"2023","journal-title":"Circulation"},{"key":"2025092303562863700_euaf185-B7","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jacep.2023.12.008","article-title":"Acute kidney injury resulting from hemoglobinuria after pulsed-field ablation in atrial fibrillation: is it preventable?","volume":"10","author":"Mohanty","year":"2024","journal-title":"JACC Clin Electrophysiol"},{"key":"2025092303562863700_euaf185-B8","doi-asserted-by":"crossref","first-page":"euad371","DOI":"10.1093\/europace\/euad371","article-title":"Severe acute kidney injury related to haemolysis after pulsed field ablation for atrial fibrillation","volume":"26","author":"Venier","year":"2023","journal-title":"Europace"},{"key":"2025092303562863700_euaf185-B9","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.jacep.2024.05.001","article-title":"Periprocedural intravascular hemolysis during atrial fibrillation ablation: a comparison of pulsed field with radiofrequency ablation","volume":"10","author":"Osmancik","year":"2024","journal-title":"JACC Clin Electrophysiol"},{"key":"2025092303562863700_euaf185-B10","doi-asserted-by":"crossref","first-page":"euae251","DOI":"10.1093\/europace\/euae251","article-title":"Intravascular haemolysis and acute kidney injury following atrial fibrillation ablation: a report using two different systems for pulsed field ablation","volume":"26","author":"De Smet","year":"2024","journal-title":"Europace"},{"key":"2025092303562863700_euaf185-B11","doi-asserted-by":"crossref","first-page":"e012732","DOI":"10.1161\/CIRCEP.124.012732","article-title":"Characterization and clinical significance of hemolysis after pulsed field ablation for atrial fibrillation: results of a multicenter analysis","volume":"17","author":"Popa","year":"2024","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025092303562863700_euaf185-B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2025.05.072","article-title":"Comparison of hemolysis with different pulsed field ablation systems","author":"Kawamura","year":"2025 4","journal-title":"Heart Rhythm"},{"key":"2025092303562863700_euaf185-B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2025.04.038","article-title":"Hemolysis after pulsed-field ablation in pulmonary vein isolation for atrial fibrillation: a prospective controlled trial","author":"Auf der Heiden","year":"2025 23","journal-title":"Heart Rhythm"},{"key":"2025092303562863700_euaf185-B14","doi-asserted-by":"crossref","first-page":"euae043","DOI":"10.1093\/europace\/euae043","article-title":"2024 European Heart Rhythm Association\/Heart Rhythm Society\/Asia Pacific Heart Rhythm Society\/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation","volume":"26","author":"Tzeis","year":"2024","journal-title":"Europace"},{"key":"2025092303562863700_euaf185-B15","doi-asserted-by":"crossref","first-page":"euad244","DOI":"10.1093\/europace\/euad244","article-title":"Progress in atrial fibrillation ablation during 25 years of Europace journal","volume":"25","author":"Boersma","year":"2023","journal-title":"Europace"},{"key":"2025092303562863700_euaf185-B16","doi-asserted-by":"publisher","first-page":"euae134","DOI":"10.1093\/europace\/euae182","article-title":"State-of-the-art pulsed field ablation for cardiac arrhythmias: ongoing evolution and future perspective","volume":"26","author":"Chun","year":"2024","journal-title":"Europace"},{"key":"2025092303562863700_euaf185-B17","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1001\/jama.293.13.1653","article-title":"The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease","volume":"293","author":"Rother","year":"2005","journal-title":"JAMA"},{"key":"2025092303562863700_euaf185-B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacep.2025.04.017","article-title":"NEMESIS-PFA: investigating collateral tissue injury associated with pulsed field ablation","author":"Lakkireddy","year":"2025 ;11","journal-title":"JACC Clin Electrophysiol"},{"key":"2025092303562863700_euaf185-B19","doi-asserted-by":"crossref","first-page":"e013317","DOI":"10.1161\/CIRCEP.124.013317","article-title":"Hemolysis after pulsed field ablation: the role of dose and contact in an acute porcine model","volume":"17","author":"Mattison","year":"2024","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025092303562863700_euaf185-B20","doi-asserted-by":"crossref","first-page":"e012765","DOI":"10.1161\/CIRCEP.124.012765","article-title":"Hemolysis after pulsed field ablation: impact of lesion number and catheter-tissue contact","volume":"17","author":"Nies","year":"2024","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025092303562863700_euaf185-B21","doi-asserted-by":"crossref","first-page":"e039190","DOI":"10.1161\/JAHA.124.039190","article-title":"Same-day discharge after catheter ablation of atrial fibrillation in the United States","volume":"14","author":"Sandhu","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"2025092303562863700_euaf185-B22","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1097\/ALN.0000000000005109","article-title":"Navigating hemolysis and the renal implications of hemoglobin toxicity in cardiac surgery","volume":"141","author":"Schaer","year":"2024","journal-title":"Anesthesiology"},{"key":"2025092303562863700_euaf185-B23","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/0310057X1704500109","article-title":"Haptoglobin and free haemoglobin during cardiac surgery-is there a link to acute kidney injury?","volume":"45","author":"Wetz","year":"2017","journal-title":"Anaesth Intensive Care"},{"key":"2025092303562863700_euaf185-B24","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/CRD.0b013e31819f1a83","article-title":"Hemolysis associated with prosthetic heart valves: a review","volume":"17","author":"Shapira","year":"2009","journal-title":"Cardiol Rev"},{"key":"2025092303562863700_euaf185-B25","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1067\/mtc.2002.120337","article-title":"Intravascular hemolysis in patients with new-generation prosthetic heart valves: a prospective study","volume":"123","author":"Mecozzi","year":"2002","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025092303562863700_euaf185-B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2025.07.026","article-title":"Renal safety of high-dose pulsed field ablation of atrial fibrillation: a prospective real-world analysis","author":"Martinez","year":"2025 22","journal-title":"Heart Rhythm"},{"key":"2025092303562863700_euaf185-B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2025.07.018","article-title":"Differences in intravascular hemolysis between 2 technologies for pulse field ablation of atrial fibrillation","author":"Mountantonakis","year":"2025 15","journal-title":"Heart Rhythm"}],"container-title":["Europace"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/europace\/advance-article-pdf\/doi\/10.1093\/europace\/euaf185\/64112178\/euaf185.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/27\/9\/euaf185\/64112178\/euaf185.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/27\/9\/euaf185\/64112178\/euaf185.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T07:56:35Z","timestamp":1758614195000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/doi\/10.1093\/europace\/euaf185\/8239992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,22]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euaf185","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,9]]},"published":{"date-parts":[[2025,8,22]]},"article-number":"euaf185"}}